PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 3 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $297,000 | -65.0% | 78,175 | -53.1% | 0.00% | -100.0% |
| Q4 2019 | $848,000 | +203.9% | 166,759 | +202.1% | 0.00% | – |
| Q3 2019 | $279,000 | -16.2% | 55,202 | +2.4% | 0.00% | – |
| Q2 2019 | $333,000 | -18.8% | 53,920 | -39.1% | 0.00% | – |
| Q1 2019 | $410,000 | +85.5% | 88,520 | +69.1% | 0.00% | – |
| Q4 2018 | $221,000 | -55.1% | 52,362 | -33.3% | 0.00% | – |
| Q3 2018 | $492,000 | -4.8% | 78,520 | +22.2% | 0.00% | -100.0% |
| Q2 2018 | $517,000 | -1.1% | 64,267 | -8.4% | 0.00% | – |
| Q1 2018 | $523,000 | +30.4% | 70,133 | +4.4% | 0.00% | – |
| Q4 2017 | $401,000 | -42.6% | 67,180 | -29.3% | 0.00% | -100.0% |
| Q3 2017 | $699,000 | -11.9% | 95,088 | -18.6% | 0.00% | 0.0% |
| Q2 2017 | $793,000 | -45.2% | 116,859 | -23.8% | 0.00% | 0.0% |
| Q1 2017 | $1,448,000 | +107.7% | 153,319 | +90.2% | 0.00% | 0.0% |
| Q4 2016 | $697,000 | +13.9% | 80,613 | -16.4% | 0.00% | 0.0% |
| Q3 2016 | $612,000 | +74.4% | 96,477 | +16.1% | 0.00% | – |
| Q2 2016 | $351,000 | -13.1% | 83,074 | -10.2% | 0.00% | – |
| Q1 2016 | $404,000 | +11.6% | 92,471 | +56.4% | 0.00% | – |
| Q4 2015 | $362,000 | +18.3% | 59,138 | +10.6% | 0.00% | – |
| Q3 2015 | $306,000 | -86.0% | 53,486 | -81.7% | 0.00% | -100.0% |
| Q2 2015 | $2,185,000 | +197.7% | 292,794 | +138.4% | 0.00% | +100.0% |
| Q1 2015 | $734,000 | -11.9% | 122,814 | +11.5% | 0.00% | 0.0% |
| Q4 2014 | $833,000 | +347.8% | 110,185 | +208.0% | 0.00% | – |
| Q3 2014 | $186,000 | -6.5% | 35,774 | -22.5% | 0.00% | – |
| Q2 2014 | $199,000 | -67.2% | 46,141 | -68.9% | 0.00% | -100.0% |
| Q1 2014 | $607,000 | -56.2% | 148,423 | -42.9% | 0.00% | 0.0% |
| Q4 2013 | $1,386,000 | +21.0% | 259,897 | +13.9% | 0.00% | 0.0% |
| Q3 2013 | $1,145,000 | +1.6% | 228,232 | -9.7% | 0.00% | 0.0% |
| Q2 2013 | $1,127,000 | -2.7% | 252,833 | +17.4% | 0.00% | 0.0% |
| Q1 2013 | $1,158,000 | – | 215,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |